Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$5.5M |
 |
Gilead SciencesGILD |
-$4.04B |
 |
AmgenAMGN |
-$189M |
 |
Editas MedicineEDIT |
-$7M |
 |
Crispr TherapeuticsCRSP |
-$171M |
Are Phio Pharmaceuticals Insiders Buying or Selling?
Phio Pharmaceuticals (PHIO) has had 5 insider transactions in the past 90 days, all buys — insider buying is generally read as a bullish signal. The most recent was PATRICIA BRADFORD, who bought 6,500 shares at $1.01 on September 24, 2026.
Insider trading patterns can signal confidence or concern from the people who know the company best. AltIndex tracks insider transactions as one of 25+ alternative data signals in the PHIO AI Score. For government officials trading this stock, see PHIO congressional trading.
Who’s Trading Phio Pharmaceuticals Stock?
| Insider | Activity | Trades | Last Trade |
|---|---|---|---|
| Robert Bitterman | Bought $51,000 | 10 | Sep 22, 2026 |
| PATRICIA BRADFORD | Bought $19,000 | 2 | Sep 24, 2026 |
| Plott Ronald Todd | Bought $17,000 | 1 | Aug 19, 2026 |
| Robert Ferrara | Bought $11,000 | 2 | Jun 10, 2025 |
Recent Phio Pharmaceuticals Insider Transactions
| Insider | Transaction Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| PATRICIA BRADFORD | Sep 24, 2026 | Buy | 6,500 | $1.01 | $6,600 |
| Robert Bitterman | Sep 22, 2026 | Buy | 2,000 | $1.03 | $2,100 |
| PATRICIA BRADFORD | Sep 15, 2026 | Buy | 12,000 | $1.03 | $12,000 |
| Plott Ronald Todd | Aug 19, 2026 | Buy | 15,000 | $1.14 | $17,000 |
| Robert Bitterman | Aug 18, 2026 | Buy | 10,000 | $1.06 | $11,000 |
| Robert Bitterman | Dec 31, 2025 | Buy | 5,000 | $1.03 | $5,200 |
| Robert Bitterman | Dec 23, 2025 | Buy | 5,000 | $1.02 | $5,100 |
| Robert Bitterman | Nov 21, 2025 | Buy | 5,000 | $1.14 | $5,700 |
| Robert Bitterman | Nov 18, 2025 | Buy | 5,000 | $1.27 | $6,400 |
| Robert Bitterman | Jun 10, 2025 | Buy | 2,000 | $2.42 | $4,800 |
| Robert Ferrara | Jun 10, 2025 | Buy | 2,500 | $2.42 | $6,000 |
| Robert Bitterman | Jun 9, 2025 | Buy | 1,500 | $2.75 | $4,100 |
| Robert Bitterman | May 22, 2025 | Buy | 1,200 | $1.78 | $2,100 |
| Robert Bitterman | May 21, 2025 | Buy | 3,000 | $1.77 | $5,300 |
| Robert Ferrara | May 20, 2025 | Buy | 2,500 | $1.82 | $4,600 |
Frequently Asked Questions: Phio Pharmaceuticals Insider Trading
In the past 90 days, Phio Pharmaceuticals insiders have made 5 buys and 0 sells. The net buying may indicate insider confidence in the company’s outlook.
Insider buying is generally a stronger signal than insider selling, since insiders may sell for personal reasons (diversification, taxes) but typically buy only when they believe the stock is undervalued. AltIndex uses insider transaction patterns alongside 25+ other signals in the AI Score.
Bitterman Robert J has bought the most PHIO stock in the last 2 years, with a total value of $51,000.
According to our estimates, the total value of insider transactions for Phio Pharmaceuticals in the last 2 years is positive, amounting to $98,000. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
